The present study showed that increasing TRPM7 activity enhanced GBM invasiveness potentially through MMP-2 upregulation, whereas our previous studies showed the vice-versa for TRPM7 inhibition [4, 5]. The gene discussed is MMP2; the disease is glioblastoma.